Why off-label options should be carefully considered to avoid the recurrence of preventable tragedies.

Drug Package Insert FDA

Within the turmoil of the COVID-19 pandemic, scientists worldwide are rushing to develop a cure. On March 20, 2020, President Trump claimed that the drug hydroxychloroquine might potentially be effective against the virus. While hydroxychloroquine is approved to treat malaria and other diseases, using it to treat COVID-19, either as a preventative measure or after symptoms have started, would be an off-label use.

Off-label describes the use of drugs for conditions or dosages not approved by the Food and Drug Administration (FDA). To market a drug, the FDA requires safety and efficacy data from controlled clinical trials. …


A growing concern during COVID-19 pandemic

Photo by National Cancer Institute on Unsplash

Drug shortages used to be a common issue that pharmacists dealt with daily. I remember physicians and nurses frustrated for the lack of vital saline solutions or anesthetics, and parents forced to drive to other counties to find the epinephrine that allowed their kids to return to school.

A growing concern in the past decade, the shortage of essential medications reached an alarming peak in 2011, the year that signaled the turning point for legislators. In 2012, President Obama signed an executive order to reduce the prescription drug shortages, requiring an early notification from manufacturers to report temporary or permanent…

Viviana Coppo

Viviana is a pharmacist and a speech pathologist.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store